Literature DB >> 6090460

The purification of tau protein and the occurrence of two phosphorylation states of tau in brain.

G Lindwall, R D Cole.   

Abstract

Two newly discovered properties of tau protein are reported; it is soluble in 2.5% perchloric acid and insoluble in 25% glycerol. These properties were exploited in the development of improved methods for the purification of tau. Treatment with perchloric acid did not alter the electrophoretic behavior of tau, and the products of the new isolation method were fully competent in the promotion of microtubule assembly. The application of the new purification techniques to bovine brain tissue demonstrated that tau exists endogenously in the dephosphorylated as well as in a phosphorylated state.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6090460

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

1.  Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau.

Authors:  D N Drechsel; A A Hyman; M H Cobb; M W Kirschner
Journal:  Mol Biol Cell       Date:  1992-10       Impact factor: 4.138

2.  Abnormal processing of multiple proteins in Alzheimer disease.

Authors:  H Zhang; N H Sternberger; L J Rubinstein; M M Herman; L I Binder; L A Sternberger
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

3.  The N terminal region of human tau is present in Alzheimer's disease protein A68 and is incorporated into paired helical filaments.

Authors:  A Crowe; H Ksiezak-Reding; W K Liu; D W Dickson; S H Yen
Journal:  Am J Pathol       Date:  1991-12       Impact factor: 4.307

4.  Pseudophosphorylation of tau protein directly modulates its aggregation kinetics.

Authors:  Edward Chang; Sohee Kim; Kelsey N Schafer; Jeff Kuret
Journal:  Biochim Biophys Acta       Date:  2010-10-23

5.  Alzheimer's neurofibrillary tangles contain unique epitopes and epitopes in common with the heat-stable microtubule associated proteins tau and MAP2.

Authors:  S H Yen; D W Dickson; A Crowe; M Butler; M L Shelanski
Journal:  Am J Pathol       Date:  1987-01       Impact factor: 4.307

6.  Modulation of tau phosphorylation and intracellular localization by cellular stress.

Authors:  S M Jenkins; M Zinnerman; C Garner; G V Johnson
Journal:  Biochem J       Date:  2000-01-15       Impact factor: 3.857

7.  The role of tau phosphorylation in transfected COS-1 cells.

Authors:  M Medina; E Montejo de Garcini; J Avila
Journal:  Mol Cell Biochem       Date:  1995-07-05       Impact factor: 3.396

8.  Doxorubicin affects tau protein metabolism in human neuroblastoma cells.

Authors:  A Argasinski; H Sternberg; B Fingado; P Huynh
Journal:  Neurochem Res       Date:  1989-10       Impact factor: 3.996

9.  Ultrastructure and biochemical composition of paired helical filaments in corticobasal degeneration.

Authors:  H Ksiezak-Reding; K Morgan; L A Mattiace; P Davies; W K Liu; S H Yen; K Weidenheim; D W Dickson
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

10.  Two-dimensional electrophoresis of tau mutants reveals specific phosphorylation pattern likely linked to early tau conformational changes.

Authors:  Alexis Bretteville; Kunie Ando; Antoine Ghestem; Anne Loyens; Séverine Bégard; Jean-Claude Beauvillain; Nicolas Sergeant; Malika Hamdane; Luc Buée
Journal:  PLoS One       Date:  2009-03-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.